Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells

New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening

Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations

Medicine, Oncology, Pharmacology +10

Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α

Robert A. Campbell, Poornima Bhat‐Nakshatri, Nikhil Patel et al. · Journal of Biological Chemistry · 2001 · 968 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Specific protection against breast cancers by cyclin D1 ablation

Qunyan Yu, Yan Geng, Piotr Siciński · Nature · 2001 · 933 citations

Medicine, Cancer Biology, Oncology +14

Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer

C. Kent Osborne, V J Bardou, Torsten Hopp et al. · JNCI Journal of the National Cancer Institute · 2003 · 782 citations

Medicine, Cancer Biology, Oncology +17

Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells.

Amy S. Clark, Kip A. West, Samantha A. Streicher et al. · PubMed · 2002 · 591 citations

Life Sciences, Oncology, Pharmacology +17